Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

hol+ Buckhead, Brookhaven & Johns Creek: Atlanta's Only Physician-Led, Whole-Body GLP-1 & Peptide Therapy Program

holplus.co

News provided by

Hol+

May 07, 2026, 09:00 ET

Share this article

Share toX

Share this article

Share toX

While Every Clinic in Atlanta Prescribes GLP-1 medications and peptides, hol+ Is the Only Practice That Treats the Whole Body — Using the 5 Body Map™ and PowerRX® Framework Created by Dr. Tasneem Bhatia, MD

ATLANTA, May 7, 2026 /PRNewswire/ -- hol+, Atlanta's premier integrative and functional medicine practice, today announced the availability of its comprehensive, physician-led GLP-1 and Peptide Therapy Program across its Buckhead, Brookhaven & Johns Creek locations — the only program of its kind in Atlanta that treats the whole body first, using the proprietary 5 Body Map™ and PowerRX® framework created by hol+ founder Dr. Tasneem Bhatia, MD (Dr. Taz).

"The explosion of interest in peptides and GLP-1 medications is exciting — and well deserved. But peptides, GLP-1 medications, and prescribed hormone therapy work best in a holistic model with physician supervision, where the whole body is taken into account. That is exactly what we do at hol+."
— Dr. Taz Bhatia, MD — Founder, hol+

In Atlanta's Buckhead, Brookhaven & Johns Creek corridors, GLP-1 medications are now available from medspa kiosks, telehealth apps, and weight loss clinics on nearly every block. Yet patient outcomes tell a different story: muscle loss, hormonal disruption, gut damage, and the frustrating plateau that arrives when the prescription is working, but the body's deeper systems are not. hol+ was built precisely for this gap.

"The market has caught up to what functional and integrative medicine has known for decades," said Dr. Bhatia. "Your body is not a single system. It is five — and if you only treat one, you will eventually hit a wall. Our patients get results because we treat all five, together, from the very first appointment."

The 5 Body Map™ & PowerRX®: The Foundation of Every hol+ Protocol

Created by Dr. Taz Bhatia, MD, the 5 Body Map™ is a whole-body assessment framework that maps every patient across five foundational body systems before any treatment begins:

The Five Body Systems Evaluated at Every hol+ Appointment

  • Hormonal System — thyroid, sex hormones, cortisol, insulin, adrenal function
  • Gastrointestinal System — gut microbiome, leaky gut, digestion, nutrient absorption
  • Immune & Inflammatory System — systemic inflammation, autoimmunity, microinflammation
  • Structural System — muscle mass, bone density, body composition, metabolic rate
  • Energetic System — cellular energy production, mitochondrial function, mental clarity, mood

PowerRX® is the personalized treatment protocol built from that map — integrating GLP-1 medications, peptide therapy, bioidentical hormones, nutrition, and functional medicine interventions into a single coordinated plan. No two PowerRX® protocols are the same because no two bodies are.

"The 5 Body Map™ is what tells us why a patient is stuck," said Dr. Bhatia. "PowerRX® is how we get them unstuck — using the best tools available, including GLP-1s and peptides, in the precise combination and sequence that works for their body."

How hol+ Differs From Every Other GLP-1 & Peptide Clinic in Atlanta

Atlanta's GLP-1 and peptide market has expanded rapidly — and with it, a category of providers offering prescriptions without context. hol+ represents a fundamentally different model:

hol+ GLP-1 & Peptide Protocol

Full 5 Body Map™ assessment across all five body systems before any protocol begins

GLP-1s, peptides, and hormone therapy integrated into a unified PowerRX® plan

Comprehensive functional lab panel — hormones, inflammation, gut, metabolic markers — before Day 1

Structural body system assessment with active muscle and body composition protection built in

Ongoing physician supervision with protocol adjustments as the body responds and rebalances

Whole-body optimization — weight, energy, hormones, cognition, gut health — addressed simultaneously

Hormonal system monitored and supported throughout; side effects anticipated and prevented

Energetic system tracked; cognitive peptides available where appropriate within the PowerRX® plan

"We see patients who have tried every GLP-1 program and stopped because of side effects, muscle loss, or plateau. When we map their five body systems, we almost always find the same thing — several systems were never addressed. That is not a medication failure. That is a model failure."
— Dr. Tasneem Bhatia, MD

Services Available Now at hol+

All services are available at all hol+ locations, delivered under ongoing physician supervision within the 5 Body Map™ framework:

GLP-1 Medications

  • Semaglutide (Ozempic / Wegovy) — physician-supervised dosing personalized to hormonal and metabolic baseline, monitored across all five body systems
  • Tirzepatide (Mounjaro / Zepbound) — dual GLP-1/GIP agonist protocol with whole-body monitoring and PowerRX® integration

Regenerative & Therapeutic Peptides

  • BPC-157, KPV, GHK-Cu & TB-500 — gut lining repair, tissue regeneration, systemic inflammation reduction — addressing the gastrointestinal and immune body systems frequently damaged by unsupervised GLP-1 use
  • Body Composition Peptides —MOTS-c, AOD, CJC 1295, Ipamorelin, Tesamorelin – target lean muscle preservation and metabolic rate support — protecting the structural body system throughout weight loss
  • Cognitive Peptides: Dihexa, NAD+ & Selank — brain fog, motivation, mood, and mental clarity — addressing the energetic body system, one of the most overlooked dimensions of metabolic health

Foundational Program Components

  • Full Functional Lab Panel — comprehensive baseline across all five body systems before any protocol begins — hormones, inflammatory markers, gut microbiome, metabolic panels
  • Ongoing Physician Supervision — every patient's protocol is monitored and adjusted by a hol+ physician throughout their program
  • PowerRX® Protocol Architecture — a personalized, integrated treatment plan that coordinates every element of the patient's care into a single whole-body strategy
  • hol+ Membership Access — Inner Circle and Concierge membership tiers provide ongoing physician access, quarterly lab reviews, and coordinated care across all hol+ locations

For Buckhead & Brookhaven Specifically

hol+ has served the Buckhead and Brookhaven communities for years — and the patient profiles in these two neighborhoods reflect the same reality: high-performing women and men running careers, families, and households at full capacity, whose bodies are carrying a load that conventional medicine and quick-prescription weight loss clinics are not equipped to address.

In Buckhead, the program speaks directly to aesthetics-conscious, health-sophisticated and high burnout risk patients who want results that last — not rapid weight loss followed by muscle depletion and hormonal disruption.

In Brookhaven, the program serves young professional families where metabolic health, energy, and longevity are as important as the number on the scale.

In Johns Creek, hol+ serves health-conscious professionals and families seeking a more comprehensive, long-term approach to metabolic health, energy, hormone balance, and longevity. The program appeals to patients looking beyond quick-fix weight loss solutions and toward sustainable, whole-body wellness.

"Buckhead, Brookhaven & Johns Creek patients have options. What they have not had is a physician-led program that treats their whole body — not just their weight. That is what hol+ offers. And it is the only model that produces results that actually hold."
— Dr. Taz Bhatia, MD

Appointments & Access

The hol+ Physician-Led GLP-1 & Peptide Program is available now at hol+ Buckhead, hol+ Brookhaven, & hol+ Johns Creek. Virtual consultations are available for patients throughout Georgia and nationally. New patient appointments can be booked at holplus.co/appointments. Program access is also available through hol+'s Inner Circle and Concierge membership tiers.

hol+ Brookhaven 1401 Dresden Drive, Atlanta, GA 30319
hol+ Johns Creek 10220 Medlock Bridge Road, Johns Creek, GA 30097
Book online: holplus.co • Virtual consultations available nationwide

ABOUT HOL+
hol+ is Atlanta's leading integrative and functional medicine practice, founded by Dr. Tasneem Bhatia, MD — board-certified in integrative medicine and pediatrics, licensed acupuncturist, Ayurvedic practitioner, and bestselling author. hol+ serves patients across Atlanta through locations in Buckhead, Brookhaven, and Johns Creek, plus virtual services nationwide. Every hol+ program is built on the 5 Body Map™ and PowerRX® framework, a whole-body assessment and treatment methodology created by Dr. Taz that evaluates patients across five interconnected body systems — ensuring that every prescription, every peptide protocol, and every treatment plan is informed by the full picture of a patient's health.
Book an appointment: holplus.co/appointments | Media contact: [email protected] | doctortaz.com 

SOURCE Hol+

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.